0

CYANOKIT از شرکت SERB SA

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CYANOKIT از شرکت SERB SA

New Drug Application (NDA): 022041

Company: SERB SA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CYANOKIT HYDROXOCOBALAMIN 5GM/VIAL (5GM/KIT) INJECTABLE;INJECTION Prescription

None

Yes Yes
CYANOKIT HYDROXOCOBALAMIN 2.5GM/VIAL (5GM/KIT) INJECTABLE;INJECTION Discontinued

None

No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/15/2006 ORIG-1 Approval

Type 3 – New Dosage Form

PRIORITY; Orphan

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/022041lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/022041s000_LTR.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/022041_cyanokit_toc.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
12/31/2018 SUPPL-20 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022041s019, 020lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/022041Orig1s019, s020ltr.pdf

12/31/2018 SUPPL-19 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022041s019, 020lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/022041Orig1s019, s020ltr.pdf

02/04/2016 SUPPL-16 Manufacturing (CMC)

Label is not available on this site.

07/03/2014 SUPPL-15 Manufacturing (CMC)

Label is not available on this site.

11/21/2013 SUPPL-13 Manufacturing (CMC)

Label is not available on this site.

04/08/2011 SUPPL-9 Labeling-Package Insert

Label (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022041s008s009lbl.pdf

04/08/2011 SUPPL-8 Labeling

Label (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022041s008s009lbl.pdf

02/19/2010 SUPPL-7 Labeling-Container/Carton Labels

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022041s007lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022041s007ltr.pdf

06/04/2009 SUPPL-5 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022041s005lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022041s005ltr.pdf

10/13/2010 SUPPL-4 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022041s004lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022041s004ltr.pdf

02/04/2016 SUPPL-1 Manufacturing (CMC)

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
12/31/2018 SUPPL-20

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022041s019, 020lbl.pdf
12/31/2018 SUPPL-19

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022041s019, 020lbl.pdf
04/08/2011 SUPPL-9

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022041s008s009lbl.pdf
04/08/2011 SUPPL-8

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022041s008s009lbl.pdf
10/13/2010 SUPPL-4

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022041s004lbl.pdf
02/19/2010 SUPPL-7

Labeling-Container/Carton Labels

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022041s007lbl.pdf
06/04/2009 SUPPL-5

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022041s005lbl.pdf
12/15/2006 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/022041lbl.pdf
بخوانید  CLORAZEPATE DIPOTASSIUM از شرکت GD SEARLE LLC
برچسب‌ها:

نظرات کاربران